Table 3.
Summary of AGP‐positivity on different leucocyte populations (number of positive/total number of cats) as a function of FCoV status
| FCoV status | Neutrophils | Lymphocytes | Monocytes | At least one | |
|---|---|---|---|---|---|
| Positive | Clinically healthy | 1/19 | 1/19 | 0/19 | 1/19 |
| Sick | 8/19* | 5/19 | 5/19* | 9/19* | |
| FIP | 4/13* | 3/13 | 2/13 | 4/13 | |
| Other diseases | 4/6* | 2/6 | 3/6* | 5/6* | |
| Total | 9/38 | 6/38 | 5/38 | 10/38 | |
| Negative | Clinically healthy | 2/13 | 1/13 | 2/13 | 2/13 |
| Other disease | 1/6 | 0/6 | 1/6 | 1/6 | |
| Total | 3/19 | 1/19 | 3/19 | 3/19 |
P < 0.05 vs clinically healthy FCoV‐positive cats.
AGP, alpha‐1‐acid glycoprotein; FCoV, feline coronavirus.